Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys
David R. Maguire, Lisa R. Gerak, Jesus J. Sanchez, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1986-1993
Open Access | Times Cited: 20

Showing 20 citing articles:

Countermeasures for Preventing and Treating Opioid Overdose
Charles P. France, Gerard P. Ahern, Saadyah Averick, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 3, pp. 578-590
Open Access | Times Cited: 54
Structural basis of μ-opioid receptor targeting by a nanobody antagonist
Jun Yu, Amit Kumar, Xuefeng Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse
Ying Han, Lu Cao, Kai Yuan, et al.
Neuroscience Bulletin (2022) Vol. 38, Iss. 11, pp. 1365-1382
Open Access | Times Cited: 19
Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?
Rita Tabanelli, Simone Brogi, Vincenzo Calderone
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10888-10888
Open Access | Times Cited: 11
Chronic administration of methocinnamox, a mu-opioid receptor antagonist, reduces hedonic response without impacting motivation in mice
Mahboob Ahmad Sheikh, Emily Cambre, Cory Langreck, et al.
Psychopharmacology (2025)
Closed Access
Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats
Víctor Jiménez, Gabriel Castaneda, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 377, Iss. 1, pp. 29-38
Open Access | Times Cited: 18
Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys
David R. Maguire, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 382, Iss. 2, pp. 181-187
Open Access | Times Cited: 12
Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
Joshua C. Zamora, Hudson R. Smith, Elaine M. Jennings, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 6
Open Access | Times Cited: 16
Behavioral pharmacology of methocinnamox: A potential new treatment for opioid overdose and opioid use disorder
David R. Maguire, Charles P. France
Journal of the Experimental Analysis of Behavior (2023) Vol. 119, Iss. 2, pp. 392-406
Open Access | Times Cited: 5
Translational value of non-human primates in opioid research
Huiping Ding, Mei‐Chuan Ko
Experimental Neurology (2021) Vol. 338, pp. 113602-113602
Open Access | Times Cited: 12
The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
Colleen Jordan, Amy L. Kennalley, Alivia L. Roberts, et al.
Pharmacy (2022) Vol. 10, Iss. 3, pp. 48-48
Open Access | Times Cited: 7
Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys
David R. Maguire
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 155-162
Closed Access | Times Cited: 7
Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys
Lisa R. Gerak, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 3, pp. 363-371
Closed Access | Times Cited: 6
Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys
David R. Maguire, Charles P. France
Neuropharmacology (2023) Vol. 243, pp. 109777-109777
Open Access | Times Cited: 3
Effects of methadone, buprenorphine, and naltrexone on actigraphy-based sleep-like parameters in male rhesus monkeys
Laís F. Berro, C. Austin Zamarripa, Joseph T Talley, et al.
Addictive Behaviors (2022) Vol. 135, pp. 107433-107433
Open Access | Times Cited: 4
The lasting impact of methocinnamox on opioid self-administration
E. Andrew Townsend
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1963-1964
Open Access | Times Cited: 4
Antinociceptive effects of fentanyl and nonopioid drugs in methocinnamox-treated rats
Saba Ghodrati, Lawrence M. Carey, Charles P. France
Drug and Alcohol Dependence (2024) Vol. 260, pp. 111320-111320
Closed Access
Evaluation of potential punishing effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rhesus monkeys responding under a choice procedure
David R. Maguire
Behavioural Pharmacology (2024) Vol. 35, Iss. 7, pp. 378-385
Closed Access
Atorvastatin facilitates extinction and prevents reinstatement of morphine-induced conditioned place preference in rats
Shiva Hashemizadeh, Elham Alaee, Niloofar Aghajani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117639-117639
Closed Access
Potential of Methocinnamox to Treat Opioid Misuse
Colleen Jordan, Amy Kennalley, Tenzing Dolma, et al.
(2022)
Open Access | Times Cited: 2
Neuroanatomical and neurochemical substrates of addiction
Justin R. Yates
Elsevier eBooks (2023), pp. 91-132
Closed Access
Page 1

Scroll to top